Table 1.
Core Intervention | Components |
---|---|
HIV testing and counselling | Includes provider-initiated testing and counseling (PITC) and testing for partners and family members |
Linkage to HIV care for those testing positive for HIV | Linkage from all HIV testing entry points |
Cotrimoxazole (CTX) prophylaxis | CTX prophylaxis for all eligible people living with HIV (PLWH) |
Tuberculosis screening | Regular screening with a symptom-based checklist Additional evaluation and treatment for those who screen positive Isoniazid preventive therapy (IPT) for those who screen negative |
Assessment of ART eligibility, with prompt ART initiation, if eligible |
WHO staging at every visit, including assessment and treatment of opportunistic illnesses Monitoring of child growth and development CD4+ testing at enrollment in care and every 6 months thereafter |
Prevention of mother-to-child transmission of HIV | Family planning services to prevent unintended pregnancy ART for all pregnant and breastfeeding women with HIV Prompt provision of antiretroviral and other prophylaxis at birth Ongoing care for HIV-infected mothers and HIV-exposed infants |
Medication monitoring and management | Monitoring of medication adherence & provision of adherence support Monitoring for and management of medication-related side effects and toxicity Monitoring for treatment response and treatment failure, with regimen adjustment, as needed |
Monitoring and supporting retention in HIV care | Appointment reminders Monitoring of appointment attendance Community-based patient groups for ART refills Outreach and tracking of those who miss appointments and/or are lost to follow-up |
Access to laboratory testing for HIV diagnosis, determining ART eligibility, monitoring treatment response, and diagnosing TB |
HIV diagnosis including rapid HIV testing and dried blood spot-based HIV-1 DNA PCR for early infant diagnosis CD4+ T-cell testing for assessing ART eligibility and monitoring treatment response Routine or targeted viral load monitoring to detect treatment failure, if available Microscopic or molecular TB diagnosis |
Psychosocial support | Patient education Counseling to support disclosure, manage stigma and discrimination Support groups Financial support and microfinance projects |
ART, antiretroviral therapy; TB, tuberculosis.